OAS2 and breast carcinoma: Activation of OAS2 in the MMTV-PyMT model of breast cancer prevented pregnancy from increasing the number of lung metastases, a finding that establishes the OAS family as therapeutic targets for the development of agents designed to prevent pregnancy from driving breast cancer metastasis.